Episodes

  • Are Compounded GLP‑1 Medications Safe?

    Are Compounded GLP‑1 Medications Safe?
    14 Oct 2026
    Compounded GLP‑1 medications are not the same as FDA‑approved products like Wegovy, Ozempic, Zepbound, or Mounjaro. Compounding can be appropriate in limited clinical situations (for example, a true allergy or a needed formulation), but it carries higher risks for inconsistent potency, contamination, and unpredictable side effects — so prioritize approved drugs when available and, if a compounded product is the only option, insist on accredited pharmacies, sterility testing, and close clinical follow‑up. For more information visit https://southfloridatrimclinic.com/.
    Show more Show less
    6 min
  • Does GLP‑1 Weight Loss Cause Hair Loss?

    Does GLP‑1 Weight Loss Cause Hair Loss?
    14 Oct 2026
    Hair loss is not a well‑established direct side effect of GLP‑1 medications like semaglutide or tirzepatide, but many people report increased hair shedding after starting treatment. In most cases the timing points to telogen effluvium — a temporary shedding triggered by rapid weight loss, changes in nutrition (especially low iron or protein), stress, or other medical causes — so tracking timing, checking simple labs, and addressing nutrition are practical first steps to take with your healthcare provider. For more information visit https://southfloridatrimclinic.com/.
    Show more Show less
    6 min
  • What Is Retatrutide and Is It Approved Yet?

    What Is Retatrutide and Is It Approved Yet?
    14 Oct 2026
    Retatrutide is an investigational “triple agonist” drug that targets GLP‑1, GIP, and glucagon receptors to reduce appetite and affect metabolism. It’s shown promising, sometimes double‑digit percentage weight loss in early trials, but it has not received FDA approval and needs larger, longer studies to confirm safety and long‑term effectiveness — so it isn’t available as a routine prescription today. For more information visit https://southfloridatrimclinic.com/.
    Show more Show less
    7 min
  • Who Should Not Take a GLP‑1 Medication?

    Who Should Not Take a GLP‑1 Medication?
    14 Oct 2026
    GLP‑1 medications like semaglutide and tirzepatide can help many people lose weight, but they aren’t appropriate for everyone. This episode explains clear exclusions (pregnancy, breastfeeding, and a personal or family history of medullary thyroid carcinoma or MEN2), important caution zones (history of pancreatitis, severe gastroparesis, and certain medication combinations), and practical steps to reduce risk—what to tell your provider, warning signs that need urgent care, and how to verify safe medication sources. For more information visit https://southfloridatrimclinic.com/.
    Show more Show less
    8 min
  • How Long Do You Need to Stay on a GLP‑1?

    How Long Do You Need to Stay on a GLP‑1?
    14 Oct 2026
    There’s no one-size-fits-all answer to how long you should stay on a GLP‑1 medication like semaglutide or tirzepatide. Duration depends on your medical reasons (for example, diabetes or sleep apnea), weight goals, how well you tolerate the drug, and whether you and your provider plan for maintenance steps to reduce rebound weight regain. This episode explains what determines treatment length, what commonly happens after stopping, and practical questions to bring to your clinician so you can make a safe, personalized plan. For more information visit https://southfloridatrimclinic.com/.
    Show more Show less
    6 min